Methods for Risk Assessment of Transgenic Plants: III. Ecological risks and prospects of transgenic plants, where do we go from here? A dialogue between biotech industry and science

Product DescriptionDiscusses ecological risks and prospects of transgenic plants. Presents the discussion sessions as well as the scientific contributions and thus mirrors the risk assessment debate based not on exaggerated negative scenarios but on critical science and hard data.
Order from Amazon –> Methods for Risk Assessment of Transgenic Plants: III. Ecological risks [...]

Aggressive Approach To Childhood Cancer Worth Risks, Review Finds

Aggressive Approach To Childhood Cancer Worth Risks, Review Finds
Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy. In light of the seriousness of the disease, some children undergo intense treatment [...]

Study Finds Avandia Safety Risks Higher Than Peer Drugs Including Actos

Copyright (c) 2008 Katie Kelley
The U.S. News & World Report recently found that the type 2 diabetes drug Avandia is “riskier than Actos, another drug in the same class.” THe results of the study were published in an issue of the Archives of Internal Medicine.
According to an article published in the New England Journal of [...]

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma

Benefits outweigh risks in myeloablative therapy for children with high-risk neuroblastoma
Neuroblastoma is among the most common of childhood cancers and fortunately, some children will get better spontaneously. Yet for children with high-risk disease the outlook is poor: more than half will relapse despite chemotherapy.
Read more on News-Medical-Net

Kidney Transplant: Risks and Outcomes

The UCSF Transplant Update Series brings the latest clinical information for physicians, nurses, allied health professionals and others who care for organ failure patients. This program provides an update in transplant outcomes at UCSF by Stephen Tomlanovich, MD, a survey of current clinical trials in kidney transplant by Flavio Vincenti, MD, and vital information on [...]

Next Page »